As of 2022, it has become apparent that industry and jurisdictional interest in reliable clinical models has increased greatly. Many issues are now raised that are not strictly about models themselves, but about use, relationship with software, sharing within the industry and much else.
Historically, the openEHR Clinical Program has centred around clinical modelling, and the (sizeable) community around the Clinical Knowledge Manager (CKM). Governance has accordingly been focussed on model artefacts.
In order to address the increasing needs as well as to introduce more formal governance, the openEHR Board has asked an informal group of 13 experts to put together a new definition of the openEHR ‘Clinical Program’ (as it will now be known) as a basis for future activities. The result so far of this may be found in the linked sub-pages of this page.
Comments and other constructive feedback are welcome in order to refine the definition of the Program described here.
Request for Comment (RFC) - ends 30 Sep 2022 (extended from 16)
We seek input from the openEHR community and beyond by 30 September 2022 on two items, found on the following pages: